Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

6 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (5)
P 4 (6)

Trial Status

Completed10
Unknown6
Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT03923556Phase 4Completed

Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery

NCT06691204RecruitingPrimary

Comparison of Adductor Pollicis and Abductor Digiti Minimi Muscles (Thumb Vs. Fifth Digit) As Sites for Neuromuscular Monitoring with Electromyography

NCT06544980RecruitingPrimary

Measuring Upper Airway Cross Sectional Areas During Residual Neuromuscular Blockade and After Reserval

NCT05760560UnknownPrimary

Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex

NCT05224648Not ApplicableCompletedPrimary

Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Neostigmine

NCT05003024Not ApplicableCompletedPrimary

Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Sugammadex

NCT05066035Phase 4Completed

Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine

NCT02697929Not ApplicableCompletedPrimary

Sugammadex/Neostigmine and Liver Transplantation

NCT05051371UnknownPrimary

Postoperative Residual Curarization in Elderly Patients in Post-anesthesia Care Unit

NCT03996655Phase 4UnknownPrimary

Different Reversal Agents in Pediatric Day-case Cancer Surgery

NCT03804346CompletedPrimary

Infantile - Postoperative Residual Curarization - Study

NCT03665805CompletedPrimary

Postoperative Residual Curarization in 2018

NCT03460509Phase 4UnknownPrimary

Reversal With Low Doses of Sugammadex in Patients Undergoing Non-cardiac Surgery

NCT03291184Not ApplicableCompletedPrimary

Postoperative Residual Paralysis After Cardiac Surgery

NCT03219138Not ApplicableCompletedPrimary

Algorithm of Muscle Function Tests to Detect Residual Neuromuscular Blockade.

NCT02698969Phase 4UnknownPrimary

Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm Ultrasonography

NCT01651572Phase 4CompletedPrimary

Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia

NCT00753389UnknownPrimary

Muscle Relaxants and Post-Anesthesia Complications

Showing all 18 trials

Research Network

Activity Timeline